Meridian Life Science, Inc.
5171 Wilfong Road
Memphis
Tennessee
38134
United States
Tel: 901-382-8716
Website: http://www.meridianlifescience.com/
Email: info@meridianlifescience.com
About Meridian Life Science, Inc.
Meridian Bioscience is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Our products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori., foodborne diseases. and respiratory infections.
For more than 30 years, Meridian Bioscience, Inc., has established a proven track record of profitable growth and product launches designed to enhance patient well being while reducing the total outcome costs of healthcare. Meridian diagnostic products are used outside of the human body and require little or no special equipment.
We maintain market leadership by responding to emerging diseases and changing medical needs. Since 1991, Meridian has developed and introduced more than 56 innovative products. Meridian also grows through acquisition, licensing, or supply agreements that have added almost 100 new products to our catalog.
Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis. We actively market our products to hospitals, reference laboratories, research centers, physician offices and diagnostics manufacturers in more than 60 countries around the world.
Our shares are traded on the NASDAQ National Market, symbol VIVO.
192 articles about Meridian Life Science, Inc.
-
Meridian Bioscience, Inc. Reports Fourth Quarter and Full-Year Fiscal 2010 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2011 Guidance
11/11/2010
-
Health Canada Approves Meridian Bioscience, Inc.'s illumigene C. difficile Molecular Amplification Assay
10/1/2010
-
Meridian Bioscience, Inc. Receives Canadian License for illumigene(TM) C. difficile
9/30/2010
-
Meridian Bioscience, Inc. Provides Sales and Earnings Guidance for Fiscal 2011 and Updates Fiscal 2010 Guidance
9/13/2010
-
Meridian Bioscience, Inc. Reports Third Quarter and Nine Months Operating Results, Declares Regular Cash Dividend, and Updates Fiscal 2010 Guidance
7/20/2010
-
Meridian Bioscience, Inc. Acquires Leading Manufacturer and Distributor of Molecular Reagents
7/20/2010
-
Meridian Bioscience, Inc. Receives FDA Clearance for New illumigene(TM) Molecular Platform
7/14/2010
-
Meridian Bioscience, Inc. Enters into Product Development and Distribution Agreement with DiaSorin S.p.A.
7/7/2010
-
Meridian Bioscience, Inc. Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
4/20/2010
-
Meridian Bioscience, Inc. Reports Second Quarter and Six Months Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
4/20/2010
-
Meridian Bioscience, Inc. Submits New illumigene(TM) Molecular C. difficile Test to U.S. FDA for Marketing Clearance
3/23/2010
-
Meridian Bioscience, Inc. Revises Guidance for Fiscal 2010 and Comments on Preliminary Second Quarter Operating Results and Business Outlook Including illumigene(TM) Update
3/17/2010
-
Meridian Bioscience, Inc. Reports Record First Quarter Sales and Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2010 Guidance
1/21/2010
-
Meridian Bioscience, Inc. Reports Record Fiscal 2009 Operating Results, Increases Regular Cash Dividend Rate, and Reaffirms Guidance
11/12/2009
-
Meridian Bioscience, Inc. to Distribute GI Disease Test in Italy
10/1/2009
-
Meridian Bioscience, Inc. Europe Announces Agreement With BUHLMANN Laboratories AG to Distribute Test For GI Disease
10/1/2009
-
Meridian Bioscience, Inc. Granted Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Analytical Sensitivity Claim to the TRU FLU(R) Test Package Insert
9/17/2009
-
Meridian Bioscience, Inc. Provides Sales and Earnings Guidance for Fiscal 2010 and Reaffirms Fiscal 2009 Guidance
9/16/2009
-
Meridian Bioscience, Inc. to Present at the Robert W. Baird 2009 Health Care Conference
9/3/2009
-
Meridian Bioscience, Inc. Reports Record Sales and Operating Results, Declares Regular Cash Dividend, Reaffirms Fiscal 2009 Guidance, and Comments on Timing of Fiscal 2010 Guidance
7/16/2009